Sterile suspension for intratracheal administration Pharmaceutical form Sterile suspension for intratracheal administration Clinical particulars Therapeutic indications Survanta is indicated for treatment of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in new born premature infants with a birth weight of 700g or greater. Survanta is also indicated for the prophylactic treatment of premature infants <32 weeks […]
